Professional Documents
Culture Documents
CARDIOVASCULAR PERSPECTIVE
T
he surging coronavirus disease 2019 (COVID-19) pandemic has raised ethi- Paul S. Chan , MD, MSc
cal and moral dilemmas that Western nations with first-rate medical care Robert A. Berg, MD
facilities rarely confront—how to best allocate standard life-saving medical Vinay M. Nadkarni, MD,
resources when escalating demand outstrips supply. Sadly, these quandaries are MS
familiar challenges in resource-poor countries. What makes this pandemic notable
is that the scope and number of reported cases have been primarily in First World
nations, raising questions in some settings about the use of emergency treatments
like resuscitation care for in-hospital cardiac arrest (IHCA). This perspective reviews
the debate around these ethical and moral dilemmas more broadly but focuses
specifically on IHCA and the response of the medical community.
To date, the impact of the COVID-19 pandemic in the United States has varied
widely by region. Already in certain areas of the United States, hospitals have run
out of intensive care unit (ICU) beds and mechanical ventilators for patients and
Downloaded from http://ahajournals.org by on February 14, 2021
personal protective equipment (PPE) for healthcare providers. Like Italian physicians
in Lombardy before them, physicians are faced with decisions about rationing of
healthcare resources. Deontological ethics emphasize that each person is valuable
and should have an equal chance of receiving life-saving care (ie, first-come, first-
served). However, this framework in some instances is becoming an exercise of
abstract argumentation as clinicians may be forced to apply utilitarian ethics to
prioritize saving the most lives in settings with extremely limited resources.
But the disconnect is that, to date, physicians in the United States have had the
luxury to practice medicine with an individual rather than a societal perspective.
We have learned from and coveted our caring relationships with fellow human
beings, and we have been largely spared from confronting medical scarcity at the
bedside. By nature, training, and experience, we practice medicine in an ethical
framework of deontology and not utilitarianism. Yet that equation changes when
facing two patients with equal need but insufficient resources to care for both.
Choosing between which patient receives life-saving care when the alternative
outcome is certain death presents a situation of imminent moral distress.
Utilitarian decision-making has been the foundation with which some regions
in Italy have handled medical personnel and extreme resource scarcity. In their
document, “Clinical Ethics Recommendations for Allocation of Care in Resource-
The opinions expressed in this article are
Limited Circumstances,” 1 the Italian Scientific Society of Anesthesiologists, Inten- not necessarily those of the editors or
sivists, and Pain Therapists recommend setting an age limit during this pandemic of the American Heart Association.
by which to deny a patient a ventilator and an ICU bed so as to maximize the ben- Key Words: emergency treatment
efit of limited intensive care resources for the greatest number of patients. Others ◼ ethics ◼ pandemic ◼ personal
in the United States have also advocated for a rationing approach in the setting of protective equipment ◼ resuscitation
ventilator and ICU bed scarcity.2–4 Critical to these policies is that these guidelines © 2020 American Heart Association, Inc.
are set by ethics teams and provide a framework by which physicians abide. Such https://www.ahajournals.org/journal/
guiding principles permit physicians during this pandemic to exit the deontological circoutcomes
Circ Cardiovasc Qual Outcomes. 2020;13:e006779. DOI: 10.1161/CIRCOUTCOMES.120.006779 May 2020 261
Chan et al; Code Blue in the COVID-19 Pandemic
framework by which they have always practiced and with COVID-19 is a healthcare worker.7 However, initia-
provide them some protection from the moral anguish tion of CPR—an aerosolizing procedure—should not be
in the impossible treatment decisions to be made. delayed before securing an invasive airway, as this will
In this ethical context, the management of IHCA, unnecessarily deprive the patient of life-saving CPR as
which affects an estimated 300 000 hospitalized patients medical providers will already be in PPE. PPE, however,
in the United States annually in a nonpandemic year, is should be conserved; thus, the total number of provid-
ever more important to address. IHCA is a medical emer- ers in the resuscitation room should be limited to essen-
gency where prompt response and treatment are criti- tial individuals for delivering CPR, securing an airway,
cal. In normal times, more than 1 in 5 patients with an administering intravenous drugs, and obtaining central
IHCA survive to hospital discharge—a marked improve- venous access if needed. For patients whose COVID-19
ment from just 2 decades ago when 1 in 8 survived to status is unknown, resuscitation team members should
discharge.5 During the COVID-19 pandemic, survival is still don PPE to protect themselves given that COVID-19
expected to be much lower as there will be substantial transmission can occur from asymptomatic patients.
delays in delivering potentially life-saving cardiopulmo- For hospitals in the midst of an overwhelming COV-
nary resuscitation (CPR) during the first minutes after ID-19 surge with an existing or imminent shortage of
IHCA as healthcare providers don PPE before initiating ventilators, ICU beds, and PPE, we expect systems to con-
resuscitations. Given the expected shortage of ventilators sider instituting a utilitarian approach to guide whether
and ICU beds for patients and PPE for providers in some or not to resuscitate any patient with IHCA, irrespective of
US regions, some have even advocated do-not-attempt- COVID-19 status. To accomplish this, each hospital may
resuscitate/allow natural death orders for all patients with need to organize an ethics team comprised of a physi-
COVID-19 irrespective of patient preferences or progno- cian, nurse, respiratory therapist, and ethicist to develop
sis.6 Other hospitals have instituted policies delaying ini- written protocols and review all admitted patients who
tiation of critical chest compressions until a patient with are not do-not-attempt-resuscitate/allow natural death
IHCA has been intubated because of the concern that during a hospitalization and determine whether, in the
CPR is an aerosol-generating procedure and thus may event of cardiac arrest, the patient should undergo resus-
endanger the health care provider. The time necessary citation efforts or be made do-not-attempt-resuscitate/
for arrival at a patient’s room, donning PPE, and securing allow natural death. If the latter, the patient would be
an invasive airway may delay CPR by up to 10 minutes. informed as to the decision and the rationale. Alloca-
Based on data from delays in CPR initiation for out-of- tion criteria could include evidence-based criteria such as
Downloaded from http://ahajournals.org by on February 14, 2021
hospital cardiac arrests, deferring initiation of CPR for 10 age and comorbidities and evolve as epidemiology and
minutes may decrease IHCA survival to far below 10% outcomes data emerge. Such allocation criteria would
for all patients irrespective of COVID-19 status. be based on a patient’s expected number of years of
As leaders in resuscitation science, we understand life left to be lived and should be agnostic to race, sex,
and appreciate concerns with resuscitation care dur- income, and position in society. The criteria ought to be
ing the COVID-19 pandemic. Yet we think there is a reviewed regularly as treatment and knowledge about
way to implement a more nuanced and contextualized COVID-19 evolves and as hospital resources change.
approach to Code Blue responses for IHCA to balance And if resources do not allow for this to occur for each
ethics, healthcare provider safety, and scarce resources. admitted patient, a hospital’s ethics team may choose to
To start, we think hospitals should implement policies focus on patients at the highest risk for clinical decline
to clarify patients’ advanced directives and their COV- and IHCA—for example, patients who are ventilated and
ID-19 status as soon as possible. All admitted patients on intravenous vasopressors. In so doing, the ethics team
regardless of COVID-19 status should have meaningful will relieve individual responding healthcare providers of
discussions about goals of care and do-not-attempt- the responsibility in making rationing decisions—ration-
resuscitate/allow natural death status on admission. ing decisions which will nonetheless occur when scarce
Next, resource management during an IHCA will vary resources in these settings are allocated on a first-come,
depending on whether one’s hospital is confronted with first-served deontological framework. Unfortunately, in
imminent and extreme resource scarcity. For hospitals some settings, the already dire circumstances may pre-
not in an extreme COVID-19 case surge but with moder- clude such an approach due to manpower.
ate to high COVID-19 prevalence in the community and Even for patients who are already on a ventila-
that have adequate ventilator and ICU bed capacity and tor, hospitals’ allocation criteria in areas with extreme
PPE for the foreseeable future, a reasonable approach resource scarcity could also recommend no resuscita-
for IHCA resuscitations can be as follows. Among tive efforts if the likelihood of survival is expected to
patients with suspected or confirmed COVID-19 dis- be extremely low to make available resources for oth-
ease, medical providers should don PPE before resuscita- ers. Within Get With The Guidelines-Resuscitation, we
tions. This is to protect healthcare providers as the Italian know that patients 80 years of age or older who have
experience has shown that 1 in 6 hospitalized patients an IHCA while on a ventilator with an initial rhythm
Circ Cardiovasc Qual Outcomes. 2020;13:e006779. DOI: 10.1161/CIRCOUTCOMES.120.006779 May 2020 262
Chan et al; Code Blue in the COVID-19 Pandemic
Circ Cardiovasc Qual Outcomes. 2020;13:e006779. DOI: 10.1161/CIRCOUTCOMES.120.006779 May 2020 263